Panmira Gets New CEO

Panmira Pharmaceuticals has appointed Hari Kumar as chief executive officer. Panmira was spun out of Amira Pharmaceuticals prior to Amira's acquisition by Bristol-Myers Squibb. Investors include Dr. Brad Bolzon (Versant Ventures), Mr. Kevin Kinsella (Avalon Ventures), Dr. David Schnell (Prospect Venture Partners) and Dr. Heath Lukatch (Novo A/S).

PeopleNorth AmericaUSBriefs